Cynorhodon bio en gélules
Food supplement declared in France, declaration No 2020-8-992, decision dated 31 August 2020
Cynorhodon bio en gélules (Bionutra) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Rosa canina 3,900 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Bionutra
- Food business operator placing the product on the market
- BTG Berlin Trade GmbH
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 - 6 gélules par jour
Declaration 170128, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Rosa canina L. | Fruit | Poudre (de plantes séchées ou broyées) | 3,900 mg |
Additives
Hydroxypropyl Méthyl Cellulose
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Note d'usage: La dose journalière conseillée ne doit pas être dépassée. Les compléments alimentaires ne peuvent pas se substituer à une alimentation équilibrée. Doit être gardé hors de portée des enfants.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Bionutra
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Cynorhodon bio en gélules (Bionutra): composition and regulation”, https://compoatlas.com/en/supplements/products/170128-cynorhodon-bio-en-gelules, updated 15 November 2026.